Skip to content

Investigating The effectiveness of telenursing training in Medication adherence and readmission rate of bipolar disorder patients

Investigating The effectiveness of telenursing training in Medication adherence and readmission rate of bipolar disorder patients discharged from Hospital

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240602061991N2
Enrollment
75
Registered
2024-10-21
Start date
2024-10-22
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bipolar disease. Bipolar disorder, current episode mixed

Interventions

Intervention 1: Intervention group: Remote follow-up training (telenursing) by the researcher and the researcher's assistant (with a master's degree and outside the research team) for 8 weeks after di

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The patient is willing to participate in the study . The patient's age should be above 18 years and below 60 years. The final diagnosis of the patient at the time of discharge from the hospital is "bipolar disorder". The degree of bipolar disorder is "moderate" or "severe". the types of bipolar disease (type one and type two). The patient should have at least reading and writing literacy The patient does not have a history of chronic illness (chronic physical pain, cancer, incurable disease). The patient does not have vision, hearing or speech problems The patient does not have drug addiction or drug use. The patient has access to a landline phone or Have a mobile phone

Exclusion criteria

Exclusion criteria: The patient should refuse to continue participating in the study and cooperating with the researcher Failure to answer the phone by the patient more than twice The patient has sudden events such as death or running away from home Occurrence of physical disorders or mental disorders during the study that prevent the patient from participating in the sessions

Design outcomes

Primary

MeasureTime frame
The first outcome: adherence to the medication regimen with the score of the Moriski MMAS-8 medication adherence questionnaire. Timepoint: At the time of discharge from the hospital and at the end of the 4th and 8th weeks of the study, the Moriski medication regimen compliance questionnaire will be completed over the phone in both groups. Method of measurement: Compliance with Morisky medication regimen (MMAS): MMAS-8 medication adherence questionnaire includes seven two-choice questions (with yes and no answers) and one Likert-type question, and question number 5 is scored against the other questions. to be The range of total scores is between 0 and 8. The lower the score, the more people will adhere to medication.;Re-hospitalization: it can be extracted in the form of an interview and by the HIS system of the hospital. Timepoint: at the time of discharge from the hospital and at the end of the 4th and 8th weeks of the study, the patients will be evaluated by the hospital's HIS system. Method of measurement: interview and by the HIS system of the hospital.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahboubeh Eslamzadeh

Mashhad University of Medical Sciences

eslamzadehmh@mums.ac.ir+98 51 3700 2398

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026